Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00125125 · ClinicalTrials.gov registry record · Phase 4
Fluvastatin in Adults With Dislipidemia With History of Muscle Problems
A Phase 4 study of Dyslipidemia, sponsored by Novartis.
- Completed
- Registry status
- Phase 4
- Development phase
- 218
- Enrollment target
- 2
- Study locations
NCT00125125: Completed Phase 4 study of Dyslipidemia, sponsored by Novartis.
NCT00125125 is a Phase 4 study of Dyslipidemia that has completed, run by Novartis. The registered enrollment target is 218 participants, below the 358-participant average among 40 other Dyslipidemia trials with a reported enrollment target (39% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00125125, a Phase 4 study of Dyslipidemia, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 218 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to find a good therapy for patients who need to be treated for high cholesterol and who have difficulty tolerating other statins (such as pravastatin, simvastatin, lovastatin, atorvastatin, rosuvastatin) due to muscle pain.
Conditions Studied
Interventions
- DRUG Fluvastatin
Study Locations (2)
New Jersey
- Novartis - East Hanover
Other
- - Investigative Centers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2005-05 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
What the finished NCT00125125 record still lists
NCT00125125 is an interventional study that assigns participants to a tested intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap, below the 358-participant average among 40 other Dyslipidemia trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Dyslipidemia appearing as the primary indexed condition, and to 1 intervention - of which Fluvastatin is the first listed.
NCT00125125 reports a single indexed study location in New Jersey, Other.
Frequently Asked Questions
What is clinical trial NCT00125125 about?
NCT00125125 is a clinical study titled "Fluvastatin in Adults With Dislipidemia With History of Muscle Problems". The purpose of the study is to find a good therapy for patients who need to be treated for high cholesterol and who have difficulty tolerating other statins (such as pravastatin, simvastatin, lovastatin, atorvastatin, rosuvastatin) due to muscle pain.
What is the current status of trial NCT00125125?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 218 participants. The study started on 2005-05. Estimated completion is 2005-12.
What conditions does trial NCT00125125 study?
This clinical trial studies the following conditions: Dyslipidemia.
What interventions are being tested in trial NCT00125125?
The interventions under investigation include: Fluvastatin (DRUG).
Who is sponsoring clinical trial NCT00125125?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00125125 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyslipidemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00125125's enrollment target sits among peer trials
218 14th of 40 higher than 27 of 40 other Dyslipidemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dyslipidemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects
COMPLETED · Phase 4
-
Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
COMPLETED · Phase 4
-
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
COMPLETED · Phase 4
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
-
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06249126 · 218 participants · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia